Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.24.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Beginning balance, value at Dec. 31, 2022 $ 24,881 $ 275,572 $ (250,219) $ (472)
Beginning balance, shares at Dec. 31, 2022   2,063,074        
Beginning balance, treasury stock, shares at Dec. 31, 2022          
Exercise of stock options, net of vesting of restricted shares 58 58
Exercise of stock options, net of vesting of restricted shares, shares   1,895        
Release of restricted stock
Release of restricted stock, shares   53,866        
Issuance of common stock under the 2018 employee stock purchase plan 48 48
Issuance of common stock under the 2018 employee stock purchase plan, shares   1,859        
Issuance of common stock in leiu of cash bonus and consulting fees 380 380
Issuance of common stock in leiu of cash bonus and consulting fees, shares   10,436        
Common stock issued upon conversion of 2022 Promissory Note 800   800  
Common stock issued upon conversion of 2022 Promissory Note, shares   67,975        
Sales of common stock, net of issuance costs 6,996   6,996
Sale of common stock, net of issuance costs, shares   382,145        
Stock-based compensation expense 3,657 3,657  
Cumulative translation adjustment 9 9
Treasury stock repurchase (502) $ (502)
Treasury stock repurchase, shares     (10,130)      
Net Income (Loss) (29,772) (29,772)
Ending balance, value at Sep. 30, 2023 6,555 $ (502) 287,511 (279,991) (463)
Ending balance, shares at Sep. 30, 2023   2,581,250        
Ending balance, treasury stock, shares at Sep. 30, 2023     (10,130)      
Beginning balance, value at Jun. 30, 2023 17,908 $ (502) 279,848 (261,012) (426)
Beginning balance, shares at Jun. 30, 2023   2,151,309        
Beginning balance, treasury stock, shares at Jun. 30, 2023     (10,130)      
Release of restricted stock
Release of restricted stock, shares   11,142        
Issuance of common stock in leiu of cash bonus and consulting fees 33 33
Issuance of common stock in leiu of cash bonus and consulting fees, shares   2,982        
Common stock issued upon conversion of 2022 Promissory Note 800 800
Common stock issued upon conversion of 2022 Promissory Note, shares   67,975        
Sales of common stock, net of issuance costs 6,001 6,001
Sale of common stock, net of issuance costs, shares   347,842        
Stock-based compensation expense 829 829  
Cumulative translation adjustment (37) (37)
Net Income (Loss) (18,979)   (18,979)
Ending balance, value at Sep. 30, 2023 6,555 $ (502) 287,511 (279,991) (463)
Ending balance, shares at Sep. 30, 2023   2,581,250        
Ending balance, treasury stock, shares at Sep. 30, 2023     (10,130)      
Beginning balance, value at Dec. 31, 2023 $ (11,457)   $ (502) 292,467 (303,004) (418)
Beginning balance, shares at Dec. 31, 2023 3,851,448 3,861,578        
Beginning balance, treasury stock, shares at Dec. 31, 2023 10,130 (10,130)      
Release of restricted stock
Release of restricted stock, shares   116,381        
Issuance of common stock in leiu of cash bonus and consulting fees 35 35
Issuance of common stock in leiu of cash bonus and consulting fees, shares   11,453        
Common stock issued upon conversion of 2022 Promissory Note 4,505 4,505
Common stock issued upon conversion of 2022 Promissory Note, shares   336,550        
Sale of common stock & exercise of prefunded warrants, net of issuance costs 42,193 $ 1 42,192
Sale of common stock & exercise of prefunded warrants, net of issuance costs, shares   7,281,187        
Fractional share issuances as a result of reverse stock split
Fractional share issuances as a result of reverse stock split, shares   141,631        
Stock-based compensation expense 1,532 1,532
Cumulative translation adjustment          
Net Income (Loss) (7,683) (7,683)
Ending balance, value at Sep. 30, 2024 $ 29,125 $ 1 $ (502) 340,731 (310,687) (418)
Ending balance, shares at Sep. 30, 2024 11,738,650 11,748,780        
Ending balance, treasury stock, shares at Sep. 30, 2024 10,130   (10,130)      
Beginning balance, value at Jun. 30, 2024 $ 14,090 $ 1 $ (502) 322,936 (307,927) (418)
Beginning balance, shares at Jun. 30, 2024   8,620,380        
Beginning balance, treasury stock, shares at Jun. 30, 2024     (10,130)      
Release of restricted stock
Release of restricted stock, shares   17,264        
Sales of common stock, net of issuance costs 17,553 17,553
Sale of common stock, net of issuance costs, shares   3,111,136        
Stock-based compensation expense 242 242
Cumulative translation adjustment          
Net Income (Loss) (2,760) (2,760)
Ending balance, value at Sep. 30, 2024 $ 29,125 $ 1 $ (502) $ 340,731 $ (310,687) $ (418)
Ending balance, shares at Sep. 30, 2024 11,738,650 11,748,780        
Ending balance, treasury stock, shares at Sep. 30, 2024 10,130   (10,130)